DCF — NORTH ARKANSAS REGIONAL MEDICAL CTR
Enterprise Value: $-190.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-190.0M
Enterprise Value
$-59.2M
PV of Cash Flows
$-130.8M
PV of Terminal Value
$-210.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $91.8M | $-12.3M | -13.0% | $-16.2M | $-14.7M |
| Year 2 | $94.5M | $-11.8M | -12.0% | $-15.8M | $-13.0M |
| Year 3 | $97.4M | $-11.1M | -11.0% | $-15.3M | $-11.5M |
| Year 4 | $100.3M | $-11.0M | -11.0% | $-15.2M | $-10.4M |
| Year 5 | $103.3M | $-11.0M | -11.0% | $-15.4M | $-9.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-190.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$89.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13936993479791449
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5